For Hire

ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, September 25, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Central District, Risk, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, News, P.C, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, Lists of schools in England, Cancer, Hindenburg, Hepatitis B virus, Technology, HIV, Defendant, Jeanne Eagels, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, Telephone, District court, G-Technology, Hindenburg Research, Identity theft, Private investigator, Renewable energy, Pharmaceutical industry, Enochian

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, September 21, 2022
Seraph, Securities Exchange Act of 1934, Complaint, Central District, Risk, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, Pomerantz, News, Lists of action films, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, LLP, Cancer, Lists of schools in England, Hindenburg, Hepatitis B virus, Technology, HIV, SEC Rule 10b-5, Defendant, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, District court, Ext, G-Technology, GLOBE, Hindenburg Research, Identity theft, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Thursday, September 15, 2022
Seraph, Securities Exchange Act of 1934, Complaint, Central District, U.S. Department of Justice Office of Legislative Affairs, Coronavirus, Justice, LLC, Company, Pomerantz, News, Lists of action films, For Hire, Person, Office of Inspector General, U.S. Department of Health and Human Services, LLP, Cancer, Lists of schools in England, Hindenburg, Hepatitis B virus, Technology, HIV, SEC Rule 10b-5, Defendant, Science, SRI, Fraud, Court, NASDAQ, China Biologic Products, District court, Ext, G-Technology, GLOBE, Hindenburg Research, Identity theft, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Tuesday, September 6, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Company, Justice, News, LLC, Fraud, Pomerantz, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Tuesday, August 30, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Justice, Company, News, LLC, Fraud, Pomerantz, Risk, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 24, 2022
Seraph, Ext, Lists of action films, HIV, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Cancer, Securities Exchange Act of 1934, SEC Rule 10b-5, Hepatitis B virus, G-Technology, District court, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, LLP, Lists of schools in England, Person, China Biologic Products, Hindenburg Research, Coronavirus, Identity theft, Defendant, Science, Court, Central District, Complaint, SRI, GLOBE, Justice, Company, News, LLC, Fraud, Pomerantz, Risk, For Hire, Hindenburg, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 17, 2022
Seraph, HIV, Identity theft, Lists of action films, Pomerantz, GLOBE, Technology, Hindenburg Research, Securities Exchange Act of 1934, Cancer, SRI, SEC Rule 10b-5, LLC, Defendant, Company, Coronavirus, LLP, Court, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Ext, G-Technology, Office of Inspector General, U.S. Department of Health and Human Services, Complaint, Fraud, Hindenburg, NASDAQ, District court, News, Science, For Hire, Hepatitis B virus, China Biologic Products, Justice, Central District, Person, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022
Seraph, HIV, Bankruptcy, Disclosure, Risk, NYSE, Â, GLOBE, Georgetown University Law Center, Technology, Ecosystem, Hindenburg Research, Coinbase, SEC, Weber, WEBR, Bloomberg, Cancer, SRI, LLC, Defendant, Texas Law Review, Coronavirus, U.S. Department of Justice Office of Legislative Affairs, U.S. Department of Defense Strategy for Operating in Cyberspace, Company, Lists of schools in England, G-Technology, Credit risk, Register, Fraud, Hindenburg, NASDAQ, News, Science, For Hire, Hepatitis B virus, Registration statement, China Biologic Products, IPO, Justice, Complaint, Identity theft, Private investigator, Renewable energy, Pharmaceutical industry, Audit, Security (finance), Cryptocurrency, P.C, Enochian

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • For more information on the Coinbase class action go to: https://bespc.com/cases/COIN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 10, 2022
Seraph, HIV, Identity theft, Lists of action films, Pomerantz, GLOBE, Technology, Hindenburg Research, Securities Exchange Act of 1934, Cancer, SRI, SEC Rule 10b-5, LLC, Defendant, Company, Coronavirus, LLP, Court, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Ext, G-Technology, Office of Inspector General, U.S. Department of Health and Human Services, Complaint, Fraud, Hindenburg, NASDAQ, District court, News, Science, For Hire, Hepatitis B virus, China Biologic Products, Justice, Central District, Person, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

Retrieved on: 
Saturday, August 6, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Central District, FBI, Risk, Private Securities Litigation Reform Act, Technology, Enron, Hindenburg Research, Securities Exchange Act of 1934, Cancer, HBV, SRI, LLC, Lawyer, History, Company, CASE, Coronavirus, Robbins Geller Rudman & Dowd LLP, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Office of Inspector General, U.S. Department of Health and Human Services, SEC, G-Technology, List of life sciences, Fraud, Hindenburg, NASDAQ, News, Science, For Hire, HIV, China Biologic Products, The Wall Street Journal, Justice, Identity theft, Complaint, Tobacco, Pharmaceutical industry, Enochian

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.